Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 03, 2022

SELL
$49.85 - $96.11 $64,904 - $125,135
-1,302 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$77.3 - $105.0 $1.15 Million - $1.56 Million
-14,816 Reduced 91.92%
1,302 $131,000
Q3 2021

Oct 25, 2021

BUY
$74.87 - $110.87 $61,093 - $90,469
816 Added 5.33%
16,118 $1.45 Million
Q2 2021

Jul 26, 2021

SELL
$66.8 - $100.45 $13,360 - $20,090
-200 Reduced 1.29%
15,302 $4.33 Million
Q1 2021

Apr 27, 2021

SELL
$59.3 - $183.85 $343,821 - $1.07 Million
-5,798 Reduced 27.22%
15,502 $4.71 Million
Q4 2020

Jan 26, 2021

BUY
$31.01 - $52.1 $106,085 - $178,234
3,421 Added 19.13%
21,300 $3.57 Million
Q3 2020

Oct 20, 2020

BUY
$15.89 - $50.51 $284,097 - $903,068
17,879 New
17,879 $716,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $513M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.